Kymera Therapeutics Inc
Ownership
Ownership Structure
Who owns Kymera Therapeutics Inc (KYMR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 80.2% of the shares are freely tradable; institutional investors hold 117.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 14.07 | 11,699,950 | +31.0 | 03/31/2026 |
| Baker Bros Advisors LP | 10.41 | 8,657,242 | +0.0 | 03/31/2026 |
| venBio Select Advisor LLC | 8.99 | 7,474,747 | +0.0 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 7.29 | 6,060,847 | -1.6 | 03/31/2026 |
| Bvf Inc | 6.62 | 5,502,710 | +0.0 | 03/31/2026 |
| T. Rowe Price Investment Management,Inc. | 6.57 | 5,464,997 | +652.2 | 03/31/2026 |
| BlackRock Inc | 6.09 | 5,060,876 | +1.1 | 03/31/2026 |
| Wellington Management Company LLP | 4.42 | 3,675,028 | -5.5 | 06/30/2026 |
| Siren, L.L.C. | 3.83 | 3,186,830 | -3.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 3.55 | 2,953,250 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Adams Brian | Chief Legal Officer | 50,254 | 5,955,099 $ | Sep 4, 2026 | direct |
| Rooney Terence | Chief Medical Officer | 38,000 | 4,503,000 $ | Jul 27, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Adams Brian | Chief Legal Officer | Sell | 2,137 | 117.57 | 251,247 |
| Sep 4, 2026 | Adams Brian | Chief Legal Officer | Sell | 3,025 | 116.81 | 353,350 |
| Sep 4, 2026 | Adams Brian | Chief Legal Officer | Sell | 1,209 | 115.55 | 139,700 |
| Jul 27, 2026 | Rooney Terence | Chief Medical Officer | Other | 38,000 | 0.00 | – |
| Apr 22, 2026 | Bruce Booth | Director | Sell | 5,900 | 89.96 | 530,764 |
| Apr 22, 2026 | Bruce Booth | Director | Sell | 100 | 90.08 | 9,008 |
| Apr 22, 2026 | Jeremy G Chadwick | COO | Sell | 300 | 90.00 | 27,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.